Fulvestrant as a reference antiestrogen and estrogen receptor (ER) degrader in preclinical studies: treatment dosage, efficacy, and implications on development of new ER-targeting agents.
作者信息
Wang Guangdi
机构信息
RCMI Cancer Research Center, Xavier University of Louisiana, New Orleans, LA, USA.
出版信息
Transl Cancer Res. 2020 Aug;9(8):4464-4468. doi: 10.21037/tcr-20-2166.
Abstract
摘要
Zotero 插件